SOURCE: Youth Enhancement Systems, Inc.

November 13, 2006 10:30 ET

YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin

MIAMI, FL -- (MARKET WIRE) -- November 13, 2006 -- Infomercial Leader Youth Enhancement Systems, Inc. (PINKSHEETS: YEHS) announced a strategic partnership with leading international distribution company Global DR Group, a sourcing and distribution company with over a decade selling successful products in over 100 countries. The company also announced it had shipped its first international orders of its flagship product ProCede, kicking off its strategic initiative of growing the ProCede brand globally with shipments to Greece, Saudi Arabia, UAE, Egypt and several other Middle Eastern countries.

YES CEO Joseph Emas believes the relationship with Global DR pushes up the timeframe for global recognition and acceptance of ProCede as the most unique product for men with thinning hair to come along in years. "I am personally excited for our shareholders and pleased that we can announce news that can have the potential impact this distribution deal has for YES."

Global DR's CFO Jose Hane sees an immediate opportunity to impact their distribution stream. "YES products like ProCede have significant international appeal." William Brand, Global DR's Group CEO, adds, "Our international partners are ecstatic over this alliance."

Scott Swank, C.O.O. of YES, concurs, and adds, "We chose Global not just because of their commitment to our flagship product ProCede, but also their commitment to providing worldwide distribution and management services for future YES products. We will source and create a pipeline of products for international rollout."

Youth Enhancement Systems is the innovator and Direct Response retailer of highly effective products and services geared toward solving problems associated with aging and other underserved sectors. YES' flagship product ProCede is consistently ranked in the top 5 most aired short form infomercials in the U.S., ranking in the top 5 for 14 consecutive months, and reaching number 1 of all products in the Health and Beauty category twice in that time period (Infomercial Monitoring Service). ProCede is clinically tested and proven safe and effective for producing fuller thicker hair shafts after just a single application.

To date, ProCede has received registration approvals in 28 foreign countries including the European Union, United Arab Emirates and South Africa and the company plans on making an announcement shortly outlining international distribution plans for its powerful patent-pending formula.

"The products in our pipeline solve problems in virtually every pertinent sector," said Ken Oxsalida, Chief Marketing Officer for the company. "You may not have heard of our company, but if you have a TV set, read newspapers, surf the net or listen to radio, you've definitely seen our products. You'll be seeing a lot more of us in the weeks to come."

For more information log on to www.youthenhancement.com or contact 866-404-5480

Certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors.

Contact Information